This report is the second study conducted by Charles River Associates on the role and impact of Health Technology Assessment (HTA) worldwide. The report assesses the performance of the HTA process in 16 countries with mature or developing HTA systems according to international best practice principles.
To read the report, please click below.
Patient burden associated with acute & chronic resistant infections
Inspiring stakeholders to take action on antimicrobial resistance (AMR) starts with communicating the current and future burden of...